Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial

Glycosaminoglycans or sulodexide has shown benefits in early experimental diabetic nephropathy (DN) models, but its efficacy in patients with early stage of DN is unknown. Methods. Twenty patients were randomly assigned to the placebo group and another 20 patients were randomly assigned to receive s...

Descripción completa

Detalles Bibliográficos
Autores principales: Satirapoj, Bancha, Kaewput, Wisit, Supasyndh, Ouppatham, Ruangkanchanasetr, Prajej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396730/
https://www.ncbi.nlm.nih.gov/pubmed/25918727
http://dx.doi.org/10.1155/2015/172038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396730/
https://www.ncbi.nlm.nih.gov/pubmed/25918727
http://dx.doi.org/10.1155/2015/172038

Ejemplares similares